The Ohio State University College of Veterinary Medicine is happy to announce a new series of short on-line lunchtime lectures on nephrology topics. We will be utilizing Carmen Connect, a university supported service for the online lectures. All you need is an internet connection and a headset or speaker/microphone.
The sessions are scheduled from 12:00 to 12:45 pm on the 3rd Tuesday of the month. The general format is 25 minutes for the presentation, followed by time for questions and case discussion. The nephrology series will be presented by Dr. Cathy Langston, DVM, DACVIM. Online Registration only needs to be completed once. Once registered, you can attend any or all of these lectures directly from your office.
This program was reviewed and approved by the AAVSB RACE program for 6 hours of continuing education.( .5 hours of CE per session attended) Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
|March 17, 2015||Diagnosis of Early CKD|
|April 21, 2015||Diagnosis of Proteinuria|
|May 19 2015||Managing Appetite in CKD|
|June 16, 2015||Phosphorus management|
|July 21, 2015||Predictors/Risks of CKD|
|Aug 18, 2015||Hypertension|
|Sept 15, 2015||Polycystic kidney disease and other cystic kidney conditions|
|Oct 20, 2015||Anemia of CKD|
|Nov 17, 2015||Managing proteinuria|
|Dec 15, 2015||Potassium Aberrations in CKD|
|Jan 19, 2016||Kidney stones in cats|
|Feb 16, 2016|
Online registration will open March 2, 2015.
For assistance with registration, contact email@example.com
For more information, contact Langston.firstname.lastname@example.org
For technical help, contact 614-688-4357 or CVM-EdTechHelp@osu.edu
Description of Topics
Diagnosis of Early CKD.
This discussion will cover diagnosing CKD in the pre-azotemic phase. After participation, the attendee should be able to perform or recommend the appropriate tests to determine if CKD is present and to distinguish between renal and non-renal causes of common abnormalities of those tests.
Diagnosis of Proteinuria.
This discussion will focus on methods of detecting and monitoring proteinuria. After participation, the attendee should know which urine protein tests are good screening tests, which have higher specificity, and understand variability in ranges when monitoring over time.
Managing Appetite in CKD.
This discussion will explore causes of anorexia in CKD, non-pharmacologic management, and drugs commonly used to treat anorexia and GI signs. After participation, the attendee should be able to counsel owners in enhancing food intake, select appropriate drugs for treatment, and be knowledgeable in the use of feeding tubes.
This discussion will cover a brief review of the pathophysiology of hyperphosphatemia, variations in dietary phosphate content, and use of phosphate binders. After participation, the attendee should have an understanding of the importance of phosphate as an indicator of progression, be able to compare phosphate content in various diets, and be comfortable with prescribing intestinal phosphate binders.
Predictors/Risks of CKD.
This discussion will focus on the epidemiology of CKD. After participation, the attendee should be able to identify pets at risk for CKD and formulate appropriate screening and monitoring programs for early detection and for monitoring for progression of early CKD.
This discussion will cover measuring blood pressure, staging, and first line treatments for hypertension. After participation, the attendee should be able to noninvasively measure blood pressure in an outpatient setting, know the IRIS stages of hypertension, and be able to select first-line treatments for hypertension.
Polycystic kidney disease and other cystic kidney conditions.
This discussion will focus on screening for PKD, expected progression, areas where management of PKD differs from CKD of other causes, and diagnosing and managing perinephric pseudocysts. After participation, the attendee should be able to use appropriate tests to screen kittens and adult cats at risk for PKD, recognize the presence of PKD, manage clinical manifestations of PKD, and be able to determine when perinephric pseudocysts merit intervention.
Anemia of CKD.
This discussion will focus on treatment of anemia associated with chronic kidney disease. After participation, the attendee should understand the factors involved in deciding when to treat anemia, how to decide whether to transfuse or give erythropoietin products, and adverse effects of erythropoietin products.
This discussion will cover antiproteinuric drugs for PLN. After participation, the attendee should know what is considered an appropriate response to antiproteinuric drugs, recognize common adverse effects of these drugs, and understand the mechanism of action of ACE inhibitors and angiotensin receptor blockers.
Potassium Aberrations in CKD.
This discussion will cover causes and treatment of hypokalemia and hyperkalemia commonly associated with CKD. After participation, the attendee should recognize clinical signs of hypokalemia, be able to prescribe appropriate potassium supplementation, and recognize common contributors to hyperkalemia in CKD.
Kidney stones in cats.
This discussion will cover detection of kidney and ureteral stones and indications for removal/urine diversion. After participation, the attendee should know when to screen for upper urinary tract urolithiasis, sensitivity of available tests, and know when to refer for intervention.
When to biopsy kidneys and what to do with the results.
This session will discuss the pros and cons of renal biopsy, general guidelines for when a biopsy should be recommended, and how to decide if immunosuppression is indicated for PLN. . After participation, the attendee should be comfortable in deciding to refer for evaluation for kidney biopsy and should recognize when immunosuppression is unlikely to be beneficial.